Barclays lowered the firm’s price target on 10x Genomics to $18 from $19 and keeps an Overweight rating on the shares. The firm expects the ...
Landmark single-cell dataset of one billion cells will be used to train new AI models to advance understanding of cellular behavior and gene function.
Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results